John Lacy III serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, John Lacy III has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 10, 2020 involved receiving (via award) 100,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 10, 2020 | PVCT | $0 | Award | 100,000 | $N/A | Discretionary |
John Lacy III currently holds 200,000 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Lacy III has been a net neutral trader of PVCT stock. They have purchased $0 and sold $0 worth of shares.
John Lacy III's most recent insider trade was on Nov 10, 2020, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted